Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 370

1.

Acceptability and potential impact of delivering sexual health promotion information through social media and dating apps to MSM in England: a qualitative study.

Kesten JM, Dias K, Burns F, Crook P, Howarth A, Mercer CH, Rodger A, Simms I, Oliver I, Hickman M, Hughes G, Weatherburn P.

BMC Public Health. 2019 Sep 6;19(1):1236. doi: 10.1186/s12889-019-7558-7.

2.

Impact of early antiretroviral treatment on sexual behaviour in the INSIGHT Strategic Timing of Anti-Retroviral Treatment (START) Trial.

Lampe FC, Rodger AJ, Burman W, Grulich A, Friedland G, Sadr WE, Neaton J, Corbelli GM, Emery S, Molina JM, Orkin C, Gatell J, Gerstoft J, Ruxrungtham K, Souza MB, Phillips A; INSIGHT START Study Group.

AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002359. [Epub ahead of print]

PMID:
31483377
3.

Pilot phase of an internet-based RCT of HIVST targeting MSM and transgender people in England and Wales: advertising strategies and acceptability of the intervention.

Witzel TC, Gabriel MM, McCabe L, Weatherburn P, Gafos M, Speakman A, Pebody R, Burns FM, Bonell C, Lampe FC, Dunn DT, Ward D, Harbottle J, Phillips AN, McCormack S, Rodger AJ.

BMC Infect Dis. 2019 Aug 8;19(1):699. doi: 10.1186/s12879-019-4247-1.

4.

An external quality assurance trial to assess mass spectrometry protein testing facilities for identifying multiple human peptides.

Horan MP, Hoffmann P, Briggs MT, Condina M, Herbert S, Ito J, Rodger A, McKay M, Maltby D, Crossett B, Abudulai LN, Clarke MW, Badrick T.

Anal Bioanal Chem. 2019 Oct;411(25):6575-6581. doi: 10.1007/s00216-019-02047-y. Epub 2019 Aug 5.

PMID:
31384985
5.

Healthcare provider and service user perspectives on STI risk reduction interventions for young people and MSM in the UK.

Roy A, King C, Gilson R, Richardson D, Burns F, Rodger A, Clark L, Miners A, Pollard A, Desai S, Bailey J, Shahmanesh M, Llewellyn C.

Sex Transm Infect. 2019 Jul 26. pii: sextrans-2018-053903. doi: 10.1136/sextrans-2018-053903. [Epub ahead of print]

6.

Combination prevention and HIV: a cross-sectional community survey of gay and bisexual men in London, October to December 2016.

Logan L, Fakoya I, Howarth A, Murphy G, Johnson AM, Rodger AJ, Burns F, Nardone A.

Euro Surveill. 2019 Jun;24(25). doi: 10.2807/1560-7917.ES.2019.24.25.1800312.

7.

An Unusual Finger Lesion in a 28-Year-Old Woman.

Dugan C, Padley H, Rodger A, Mahungu T, Cropley I.

Clin Infect Dis. 2019 Jun 18;69(1):179-181. doi: 10.1093/cid/ciy705. No abstract available.

PMID:
31209493
8.

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.

Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Raben D, Coll P, Antinori A, Nwokolo N, Rieger A, Prins JM, Blaxhult A, Weber R, Van Eeden A, Brockmeyer NH, Clarke A, Del Romero Guerrero J, Raffi F, Bogner JR, Wandeler G, Gerstoft J, Gutiérrez F, Brinkman K, Kitchen M, Ostergaard L, Leon A, Ristola M, Jessen H, Stellbrink HJ, Phillips AN, Lundgren J; PARTNER Study Group.

Lancet. 2019 Jun 15;393(10189):2428-2438. doi: 10.1016/S0140-6736(19)30418-0. Epub 2019 May 2.

9.

'Just another vial…': a qualitative study to explore the acceptability and feasibility of routine blood-borne virus testing in an emergency department setting in the UK.

Cullen L, Grenfell P, Rodger A, Orkin C, Mandal S, Rhodes T.

BMJ Open. 2019 May 1;9(4):e024085. doi: 10.1136/bmjopen-2018-024085.

10.

Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trial.

Miltz AR, Lampe FC, Bacchus LJ, McCormack S, Dunn D, White E, Rodger A, Phillips AN, Sherr L, Clarke A, McOwan A, Sullivan A, Gafos M.

BMC Public Health. 2019 Apr 25;19(1):431. doi: 10.1186/s12889-019-6757-6.

11.

Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the AURAH2 study.

Sewell J, Cambiano V, Speakman A, Lampe FC, Phillips A, Stuart D, Gilson R, Asboe D, Nwokolo N, Clarke A, Rodger AJ.

Int J Drug Policy. 2019 Jun;68:54-61. doi: 10.1016/j.drugpo.2019.03.021. Epub 2019 Apr 15.

12.

Preferences for HIV testing services among men who have sex with men in the UK: A discrete choice experiment.

Miners A, Nadarzynski T, Witzel C, Phillips AN, Cambiano V, Rodger AJ, Llewellyn CD.

PLoS Med. 2019 Apr 11;16(4):e1002779. doi: 10.1371/journal.pmed.1002779. eCollection 2019 Apr.

13.

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease.

Srivastava A, Gailer R, Tanwar S, Trembling P, Parkes J, Rodger A, Suri D, Thorburn D, Sennett K, Morgan S, Tsochatzis EA, Rosenberg W.

J Hepatol. 2019 Aug;71(2):371-378. doi: 10.1016/j.jhep.2019.03.033. Epub 2019 Apr 6.

14.

Sexual risk reduction interventions for patients attending sexual health clinics: a mixed-methods feasibility study.

King C, Llewellyn C, Shahmanesh M, Abraham C, Bailey J, Burns F, Clark L, Copas A, Howarth A, Hughes G, Mercer C, Miners A, Pollard A, Richardson D, Rodger A, Roy A, Gilson R.

Health Technol Assess. 2019 Mar;23(12):1-122. doi: 10.3310/hta23120.

15.

HIV Testing and Sexual Health Among Black African Men and Women in London, United Kingdom.

Fakoya I, Logan L, Ssanyu-Sseruma W, Howarth A, Murphy G, Johnson AM, Nardone A, Rodger AJ, Burns F.

JAMA Netw Open. 2019 Mar 1;2(3):e190864. doi: 10.1001/jamanetworkopen.2019.0864.

16.

Seroprevalence of HCV, HBV and HIV in two inner-city London emergency departments.

Cieply L, Simmons R, Ijaz S, Kara E, Rodger A, Rosenberg W, McGuinness A, Mbisa JL, Ledesma J, Ohemeng-Kumi N, Dicks S, Potts H, Lattimore S, Mandal S.

Epidemiol Infect. 2019 Jan;147:e145. doi: 10.1017/S0950268819000360.

17.

Associations of depression and anxiety symptoms with sexual behaviour in women and heterosexual men attending sexual health clinics: a cross-sectional study.

Coyle RM, Lampe FC, Miltz AR, Sewell J, Anderson J FRCP, Apea V, Collins S, Dhairyawan R, Johnson AM, Lascar M, Mann S, O'Connell R, Sherr L, Speakman A, Tang A, Phillips AN, Rodger A; AURAH Study Group.

Sex Transm Infect. 2019 Jun;95(4):254-261. doi: 10.1136/sextrans-2018-053689. Epub 2019 Feb 27.

18.

Etiology and Severity of Liver Disease in HIV-Positive Patients With Suspected NAFLD: Lessons From a Cohort With Available Liver Biopsies.

Iogna Prat L, Roccarina D, Lever R, Lombardi R, Rodger A, Hall A, Luong TV, Bhagani S, Tsochatzis EA.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):474-480. doi: 10.1097/QAI.0000000000001942.

PMID:
30807482
19.

Correction to "Supramolecular Nucleoside-Based Gel: Molecular Dynamics Simulation and Characterization of Its Nanoarchitecture and Self-Assembly Mechanism".

Angelerou MGF, Frederix PWJM, Wallace M, Yang B, Rodger A, Adams DJ, Marlow M, Zelzer M.

Langmuir. 2019 Feb 19;35(7):2885. doi: 10.1021/acs.langmuir.9b00009. Epub 2019 Feb 7. No abstract available.

20.

Linear dichroism of visible-region chromophores using M13 bacteriophage as an alignment scaffold.

Tridgett M, Moore-Kelly C, Duprey JHA, Iturbe LO, Tsang CW, Little HA, Sandhu SK, Hicks MR, Dafforn TR, Rodger A.

RSC Adv. 2018 Aug 23;8(52):29535-29543. doi: 10.1039/c8ra05475d. Epub 2018 Aug 20.

21.

Aetiology and severity of liver disease in HIV positive patients with suspected NAFLD: lessons from a cohort with available liver biopsies.

Iogna Prat L, Roccarina D, Lever R, Lombardi R, Rodger A, Hall A, Luong TV, Bhagani S, Tsochatzis E.

J Acquir Immune Defic Syndr. 2018 Dec 12. doi: 10.1097/QAI.0000000000001942. [Epub ahead of print]

PMID:
30570530
22.

Fluorescence detected linear dichroism of small molecules oriented on polyethylene film.

Wemyss AM, Razmkhah K, Chmel NP, Rodger A.

Analyst. 2018 Nov 19;143(23):5805-5811. doi: 10.1039/c8an01588k.

PMID:
30358781
23.

Protocol, rationale and design of SELPHI: a randomised controlled trial assessing whether offering free HIV self-testing kits via the internet increases the rate of HIV diagnosis.

Gabriel MM, Dunn DT, Speakman A, McCabe L, Ward D, Witzel TC, Harbottle J, Collins S, Gafos M, Burns FM, Lampe FC, Weatherburn P, Phillips A, McCormack S, Rodger AJ.

BMC Infect Dis. 2018 Oct 23;18(1):531. doi: 10.1186/s12879-018-3433-x.

24.

Light scattering corrections to linear dichroism spectroscopy for liposomes in shear flow using calcein fluorescence and modified Rayleigh-Gans-Debye-Mie scattering.

Dorrington G, Chmel NP, Norton SR, Wemyss AM, Lloyd K, Praveen Amarasinghe D, Rodger A.

Biophys Rev. 2018 Oct;10(5):1385-1399. doi: 10.1007/s12551-018-0458-8. Epub 2018 Sep 25. Review.

25.

Rationalisation of a mechanism for sensing single point variants in target DNA using anthracene-tagged base discriminating probes.

Duprey JHA, Bassani DM, Hyde EI, Jonusauskas G, Ludwig C, Rodger A, Spencer N, Vyle JS, Wilkie J, Zhao ZY, Tucker JHR.

Org Biomol Chem. 2018 Sep 11;16(35):6576-6585. doi: 10.1039/c8ob01710g.

PMID:
30168560
26.

Supramolecular Nucleoside-Based Gel: Molecular Dynamics Simulation and Characterization of Its Nanoarchitecture and Self-Assembly Mechanism.

Angelerou MGF, Frederix PWJM, Wallace M, Yang B, Rodger A, Adams DJ, Marlow M, Zelzer M.

Langmuir. 2018 Jun 12;34(23):6912-6921. doi: 10.1021/acs.langmuir.8b00646. Epub 2018 May 29. Erratum in: Langmuir. 2019 Feb 19;35(7):2885.

27.

Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013-2016.

Sewell J, Cambiano V, Miltz A, Speakman A, Lampe FC, Phillips A, Stuart D, Gilson R, Asboe D, Nwokolo N, Clarke A, Hart G, Rodger A.

Sex Transm Infect. 2018 Nov;94(7):494-501. doi: 10.1136/sextrans-2017-053439. Epub 2018 Apr 26.

28.

Getting the balance right-tackling the obesogenic environment by reducing unhealthy options in a hospital shop without affecting profit.

Simpson N, Bartley A, Davies A, Perman S, Rodger AJ.

J Public Health (Oxf). 2018 Dec 1;40(4):e545-e551. doi: 10.1093/pubmed/fdy053.

PMID:
29635521
29.

Designing a brief behaviour change intervention to reduce sexually transmitted infections: a discrete choice experiment.

Miners A, Llewellyn C, King C, Pollard A, Roy A, Gilson R, Rodger A, Burns F, Shahmanesh M.

Int J STD AIDS. 2018 Aug;29(9):851-860. doi: 10.1177/0956462418760425. Epub 2018 Apr 8.

30.

Ethnicity and sexual risk in heterosexual people attending sexual health clinics in England: a cross-sectional, self-administered questionnaire study.

Coyle RM, Miltz AR, Lampe FC, Sewell J, Phillips AN, Speakman A, Dhar J, Sherr L, Sadiq ST, Taylor S, Ivens DR, Collins S, Elford J, Anderson J, Rodger A; AURAH Study Group.

Sex Transm Infect. 2018 Aug;94(5):384-391. doi: 10.1136/sextrans-2017-053308. Epub 2018 Mar 8.

31.

Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab.

Brogan K, Precup M, Rodger A, Young D, Gilmour DF.

BMC Ophthalmol. 2018 Feb 9;18(1):37. doi: 10.1186/s12886-018-0701-x.

32.

Fluorescence detected linear dichroism spectroscopy: A selective and sensitive probe for fluorophores in flow-oriented systems.

Wemyss AM, Chmel NP, Lobo DP, Sutherland JA, Dafforn TR, Rodger A.

Chirality. 2018 Mar;30(3):227-237. doi: 10.1002/chir.22795. Epub 2018 Jan 3.

PMID:
29314266
33.

A pilot study to understand feasibility and acceptability of stool and cord blood sample collection for a large-scale longitudinal birth cohort.

Bailey SR, Townsend CL, Dent H, Mallet C, Tsaliki E, Riley EM, Noursadeghi M, Lawley TD, Rodger AJ, Brocklehurst P, Field N.

BMC Pregnancy Childbirth. 2017 Dec 28;17(1):439. doi: 10.1186/s12884-017-1627-7.

34.

Eligibility for PrEP among MSM attending GUM clinics in the UK.

Miltz AR, Cambiano V, Lampe FC, Sewell J, Speakman A, Phillips AN, Ivens DR, Asboe D, Collins S, Brady M, Nwokolo NC, Rodger AJ; AURAH Study Group.

Sex Transm Infect. 2017 Dec;93(8):571. doi: 10.1136/sextrans-2017-053268. No abstract available.

PMID:
29175993
35.

Resilience and Physical and Mental Well-Being in Adults with and Without HIV.

McGowan JA, Brown J, Lampe FC, Lipman M, Smith C, Rodger A.

AIDS Behav. 2018 May;22(5):1688-1698. doi: 10.1007/s10461-017-1980-6.

36.

Implications for a policy of initiating antiretroviral therapy in people diagnosed with human immunodeficiency virus: the CAPRA research programme.

Miltz A, Phillips AN, Speakman A, Cambiano V, Rodger A, Lampe FC.

Southampton (UK): NIHR Journals Library; 2017 Oct.

37.

Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation.

Cambiano V, Miners A, Dunn D, McCormack S, Ong KJ, Gill ON, Nardone A, Desai M, Field N, Hart G, Delpech V, Cairns G, Rodger A, Phillips AN.

Lancet Infect Dis. 2018 Jan;18(1):85-94. doi: 10.1016/S1473-3099(17)30540-6. Epub 2017 Oct 17.

38.

Self-Reported Decline in Everyday Function, Cognitive Symptoms, and Cognitive Function in People With HIV.

Laverick R, Haddow L, Daskalopoulou M, Lampe F, Gilson R, Speakman A, Antinori A, Bruun T, Vassilenko A, Collins S, Rodger A; Cognitive Impairment in People with HIV in the European Region (CIPHER) Study Group.

J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):e74-e83. doi: 10.1097/QAI.0000000000001468.

PMID:
29016449
39.

Hepatitis B, hepatitis C, and mortality among HIV-positive individuals.

Thornton AC, Jose S, Bhagani S, Chadwick D, Dunn D, Gilson R, Main J, Nelson M, Rodger A, Taylor C, Youssef E, Leen C, Gompels M, Kegg S, Schwenk A, Sabin C; UK Collaborative HIV cohort (UK CHIC) steering committee.

AIDS. 2017 Nov 28;31(18):2525-2532. doi: 10.1097/QAD.0000000000001646.

40.

Beyond the Discovery Void: New targets for antibacterial compounds.

Broughton CE, Van Den Berg HA, Wemyss AM, Roper DI, Rodger A.

Sci Prog. 2016 Jun 1;99(2):153-182. doi: 10.3184/003685016X14616130512308.

PMID:
28742471
41.

Condomless sex in HIV-diagnosed men who have sex with men in the UK: prevalence, correlates, and implications for HIV transmission.

Daskalopoulou M, Rodger AJ, Phillips AN, Sherr L, Elford J, McDonnell J, Edwards S, Perry N, Wilkins E, Collins S, Johnson AM, Burman WJ, Speakman A, Lampe FC; ASTRA Study Group.

Sex Transm Infect. 2017 Dec;93(8):590-598. doi: 10.1136/sextrans-2016-053029. Epub 2017 Jul 5.

42.

Risk, reassurance and routine: a qualitative study of narrative understandings of the potential for HIV self-testing among men who have sex with men in England.

Witzel TC, Weatherburn P, Rodger AJ, Bourne AH, Burns FM.

BMC Public Health. 2017 May 22;17(1):491. doi: 10.1186/s12889-017-4370-0.

43.

Clinically significant depressive symptoms and sexual behaviour among men who have sex with men.

Miltz AR, Rodger AJ, Sewell J, Speakman A, Phillips AN, Sherr L, Gilson RJ, Asboe D, Nwokolo NC, Clarke A, Gompels MM, Allan S, Collins S, Lampe FC; AURAH Study Group.

BJPsych Open. 2017 May 8;3(3):127-137. doi: 10.1192/bjpo.bp.116.003574. eCollection 2017 May.

44.

Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers.

Lombardi R, Lever R, Smith C, Marshall N, Rodger A, Bhagani S, Tsochatzis E.

Ann Gastroenterol. 2017;30(3):349-356. doi: 10.20524/aog.2017.0141. Epub 2017 Apr 3.

45.

Consolidating emerging evidence surrounding HIVST and HIVSS: a rapid systematic mapping protocol.

Witzel TC, Weatherburn P, Burns FM, Johnson CC, Figueroa C, Rodger AJ.

Syst Rev. 2017 Apr 5;6(1):72. doi: 10.1186/s13643-017-0452-4.

46.

Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses.

Burch LS, Smith CJ, Anderson J, Sherr L, Rodger AJ, O'Connell R, Geretti AM, Gilson R, Fisher M, Elford J, Jones M, Collins S, Azad Y, Phillips AN, Speakman A, Johnson MA, Lampe FC.

Lancet Public Health. 2016 Nov;1(1):e26-e36. doi: 10.1016/S2468-2667(16)30002-0.

47.

Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection.

Brown J, McGowan JA, Chouial H, Capocci S, Smith C, Ivens D, Johnson M, Sathia L, Shah R, Lampe FC, Rodger A, Lipman M.

HIV Med. 2017 Sep;18(8):604-612. doi: 10.1111/hiv.12497. Epub 2017 Mar 13.

48.

Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics.

Sewell J, Miltz A, Lampe FC, Cambiano V, Speakman A, Phillips AN, Stuart D, Gilson R, Asboe D, Nwokolo N, Clarke A, Collins S, Hart G, Elford J, Rodger AJ; Attitudes to and Understanding of Risk of Acquisition of HIV (AURAH) Study Group.

Int J Drug Policy. 2017 May;43:33-43. doi: 10.1016/j.drugpo.2017.01.001. Epub 2017 Feb 10.

PMID:
28189979
49.

Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients.

Haddow LJ, Laverick R, Daskalopoulou M, McDonnell J, Lampe FC, Gilson R, Speakman A, Antinori A, Balestra P, Bruun T, Gerstoft J, Nielsen L, Vassilenko A, Collins S, Rodger AJ; Cognitive Impairment in People with HIV in the European Region (CIPHER) Study Group.

AIDS Behav. 2018 May;22(5):1573-1583. doi: 10.1007/s10461-017-1683-z.

50.

Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study.

Logan S, Rodger A, Maynard-Smith L, O'Beirne J, Fernandez T, Ferro F, Smith C, Bhagani S.

World J Hepatol. 2016 Dec 28;8(36):1623-1628. doi: 10.4254/wjh.v8.i36.1623.

Supplemental Content

Loading ...
Support Center